Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hasan Sami Goksoy"'
Publikováno v:
Journal of Assisted Reproduction and Genetics.
Autor:
Ali Zahit Bolaman, İdris İnce, Zübeyde Nur Özkurt, Elgün Abishov, Ömür Gökmen Sevindik, Hüseyin Saffet Beköz, Ahmet Muzaffer Demir, Irfan Yavasoglu, Veysel Erol, Muzaffer Keklik, Zeynep Arzu Yegin, Arzu Akyay, Vildan Ozkocaman, Hilal Eroğlu Küçükdiler, Münci Yağcı, Meral Beksac, Gunhan Gurman, Cem Selim, Meltem Kurt Yuksel, Ali Dogan, Vildan Gürsoy, Serhat Çelik, Senem Maral, Umut Yilmaz, Leylagül Kaynar, Osman Ilhan, Hava Üsküdar Teke, Güner Hayri Özsan, Berrin Balık Aydın, Ufuk Demirci, Unal Atas, Selami Kocak Toprak, Sinem Civriz Bozdag, Fahir Özkalemkaş, Tekin Aksu, Nil Güler, Guldane Cengiz Seval, Reyhan Diz Küçükkaya, Özcan Çeneli, Yaşa Gül Mutlu, Eren Gündüz, Lale Aydın Kaynar, Sule Unal, Volkan Baş, Boran Yavuz, Pervin Topcuoglu, Hatice Terzi, Fehmi Hindilerden, Zeynep Tuğba Güven, Canan Albayrak, Yasemin Yavuz, Ferda Can, Muhlis Cem Ar, Neslihan Andic, İpek Yönal Hindilerden, Sinan Demircioğlu, Hasan Sami Goksoy, Rafiye Ciftciler, Mustafa Baydar, Soğol Sadri, Muhit Ozcan, Hamza Abbasov, Orhan Kemal Yücel, Sevil Sadri
Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0e580151a54b4a20ef926b2166df4c
https://avesis.deu.edu.tr/publication/details/82513f28-7a67-4796-aeda-6d220d3d7f2b/oai
https://avesis.deu.edu.tr/publication/details/82513f28-7a67-4796-aeda-6d220d3d7f2b/oai
Autor:
Hasan Sami Goksoy, Sevgi Kalayoglu Besisik, Zübeyde Nur Özkurt, Mehmet Sönmez, Sinem Civriz Bozdag, Irfan Yavasoglu, Tugrul Elverdi, Özgür Mehtap, Orhan Ayyildiz, Ahmet Kursad Gunes, Meliha Nalcaci, Burhan Ferhanoglu, Sebnem Izmir Guner, Meltem Kurt Yuksel, Elif Birtas Atesoglu, Selami Kocak Toprak, Tuğçe Nur Yiğenoğlu, Mustafa Pehlivan, Birol Yildiz, Ozan Salim, Rahsan Yildirim, Tayfur Toptas, Leylagül Kaynar, Ant Uzay, Murat Albayrak, Gülsüm Özet, Güray Saydam, Murat Ozbalak, Fevzi Altuntaş, İpek Yönal Hindilerden, Meltem Ayli, Olga Meltem Akay, Mehmet Hilmi Dogu
Publikováno v:
Web of Science
The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT). Thus, we aimed to determine th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a7c1c4c72fda6e1343d54d2a49939b
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
https://avesis.gazi.edu.tr/publication/details/e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94/oai
Publikováno v:
Modern rheumatology case reports. 7(1)
Takayasu arteritis (TA) is a large-vessel vasculitis that predominantly affects the aorta and although it usually causes stenosis, aneurysms have been reported in ∼10–25% of the patients. Here, we present a male TA patient with chronic disseminat
Autor:
null Olga Meltem Akay, null Murat Ozbalak, null Mustafa Pehlivan, null Birol Yildiz, null Ant Uzay, null Tugce Nur Yigenoglu, null Tugrul Elverdi, null Leylagul Kaynar, null Orhan Ayyildiz, null Ipek Yonal Hindilerden, null Hasan Sami Goksoy, null Sebnem Izmir Guner, null Ahmet Kursad Gunes, null Mehmet Sonmez, null Meltem Kurt Yuksel, null Sinem Civriz Bozdag, null Zubeyde Nur Ozkurt, null Tayfur Toptas, null Mehmet Hilmi Dogu, null Ozan Salim, null Guray Saydam, null Irfan Yavasoglu, null Meltem Ayli, null Gulsum Ozet, null Murat Albayrak, null Elif Birtas Atesoglu, null Selami K. Toprak, null Rahsan Yildirim, null Ozgur Mehtap, null Sevgi Kalayoglu Besisik, null Meliha Nalcaci, null Fevzi Altuntas, null Burhan Ferhanoglu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a169dfe3149b0b8d46caf5c1faf24b5a
https://doi.org/10.1002/hon.2897/v2/response1
https://doi.org/10.1002/hon.2897/v2/response1
Autor:
Güray Saydam, Mehmet Hilmi Dogu, Elif Birtas Atesoglu, Murat Ozbalak, Meltem Ayli, Sevgi Kalayoglu Besisik, Zübeyde Nur Özkurt, Leylagül Kaynar, Gülsüm Özet, Meltem Kurt Yuksel, Murat Albayrak, Mustafa Pehlivan, Birol Yildiz, Ant Uzay, Irfan Yavasoglu, Tuğçe Nur Yiğenoğlu, Mehmet Sönmez, Ozan Salim, Rahsan Yildirim, Tayfur Toptas, Tugrul Elverdi, Selami Kocak Toprak, Özgür Mehtap, Ahmet Kursad Gunes, Orhan Ayyildiz, Meliha Nalcaci, Olga Meltem Akay, Hasan Sami Goksoy, Sinem Civriz Bozdag, Burhan Ferhanoglu, Sebnem Izmir Guner, Fevzi Altuntaş, İpek Yönal Hindilerden
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S368-S369
Context The AETHERA trial reported an increased progression-free survival (PFS) when brentuximab vedotin (BV) was used as maintenance therapy in high-risk Hodgkin lymphoma (HL) after autologous stem cell transplantation (ASCT). Objective To determine
Autor:
Sevgi Kalayoglu Besisik, Emre Tekgündüz, Seckin Cagirgan, Hasan Sami Goksoy, Suleyman Sami Karti, Hakan Goker, Meral Beksac, Mehmet Sönmez, Mehmet Turgut, Münci Yağcı, Inci Alacacioglu, Zafer Gulbas, Yildiz Aydin, Emel Gürkan, Rahsan Yildirim, Leylagül Kaynar, Sibel Hacioglu, Semra Paydas, Osman Ilhan, Pelin Aytan, Tulin Firatli Tuglular, Hakan Ozdogu, Soner Solmaz, Filiz Vural, Ahmet Kursad Gunes
The present study investigated the efficacy and safety profile of daratumumab monotherapy in 42 patients with relapsed refractory multiple myeloma through a Turkish early access program. the current findings have confirmed the efficacy of daratumumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04cead7fb95577b254c3d60aad0a1782
https://avesis.gazi.edu.tr/publication/details/2aabaa90-d582-4926-acf4-7d4402c685cb/oai
https://avesis.gazi.edu.tr/publication/details/2aabaa90-d582-4926-acf4-7d4402c685cb/oai
Autor:
Ismail Faruk Durmus, Hasan Sami Goksoy, Ömer Uzel, Ayse Okumus, Esat Mahmut Ozsahin, Müge Gökçe, Bora Tas
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 129(3)
Purpose To report the feasibility, accuracy, and reliability of volumetric modulated arc therapy (VMAT)-based total-body irradiation (TBI) treatment in patients with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL). Materials and me
Autor:
Sahre Özpolat, Ebru Yilmaz, Seher Ünal, Meliha Nalcaci, Hasan Sami Goksoy, H. Tahsin Özpolat, Oner Dogan
Publikováno v:
Blood research
Background Bone marrow involvement (BMI) affects the lymphoma stage, survival, and treatment. Bone marrow biopsy (BMB) and fluorodeoxyglucose (FDG) positron emission tomography- computed tomography (PET/CT) are useful techniques to detect BMI. Both h
Publikováno v:
Journal of Assisted Reproduction & Genetics; May2023, Vol. 40 Issue 5, p1163-1171, 9p